Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.700
-0.060 (-3.41%)
At close: Apr 28, 2026, 4:00 PM EDT
1.730
+0.030 (1.76%)
After-hours: Apr 28, 2026, 6:16 PM EDT

Pyxis Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Revenue
13.8616.15---
Upgrade
Revenue Growth (YoY)
-14.17%----
Upgrade
Cost of Revenue
2.390.48---
Upgrade
Gross Profit
11.4715.67---
Upgrade
Selling, General & Admin
19.6222.4930.8337.3518.66
Upgrade
Research & Development
73.758.7549.5986.1351.05
Upgrade
Operating Expenses
93.3281.2480.42123.4869.72
Upgrade
Operating Income
-81.85-65.57-80.42-123.48-69.72
Upgrade
Interest & Investment Income
3.617.046.632.760.02
Upgrade
Earnings From Equity Investments
-----0.23
Upgrade
Other Non Operating Income (Expenses)
-----6.05
Upgrade
EBT Excluding Unusual Items
-78.24-58.53-73.79-120.72-75.98
Upgrade
Pretax Income
-78.24-79.5-73.79-120.72-75.98
Upgrade
Income Tax Expense
1.39-2.16---
Upgrade
Net Income
-79.62-77.33-73.79-120.72-75.98
Upgrade
Net Income to Common
-79.62-77.33-73.79-120.72-75.98
Upgrade
Shares Outstanding (Basic)
625840338
Upgrade
Shares Outstanding (Diluted)
625840338
Upgrade
Shares Change (YoY)
6.33%46.46%20.80%288.93%724.14%
Upgrade
EPS (Basic)
-1.28-1.32-1.85-3.65-8.95
Upgrade
EPS (Diluted)
-1.28-1.32-1.85-3.65-8.95
Upgrade
Free Cash Flow
-63.51-57.91-77.44-95.73-35.87
Upgrade
Free Cash Flow Per Share
-1.02-0.99-1.94-2.90-4.22
Upgrade
Gross Margin
82.77%97.06%---
Upgrade
Operating Margin
-590.60%-406.11%---
Upgrade
Profit Margin
-574.55%-478.95%---
Upgrade
Free Cash Flow Margin
-458.30%-358.66%---
Upgrade
EBITDA
-77.33-62.59-78.49-122.77-69.07
Upgrade
D&A For EBITDA
4.512.981.930.710.65
Upgrade
EBIT
-81.85-65.57-80.42-123.48-69.72
Upgrade
Revenue as Reported
13.8616.15---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.